was read the article
array:23 [ "pii" => "S1665268119319805" "issn" => "16652681" "doi" => "10.1016/S1665-2681(19)31980-5" "estado" => "S300" "fechaPublicacion" => "2006-01-01" "aid" => "71639" "copyright" => "Fundación Clínica Médica Sur, A.C." "copyrightAnyo" => "2006" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Ann Hepatol. 2006;5 Supl 1:S74" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 53 "formatos" => array:3 [ "EPUB" => 12 "HTML" => 14 "PDF" => 27 ] ] "itemAnterior" => array:19 [ "pii" => "S1665268119319799" "issn" => "16652681" "doi" => "10.1016/S1665-2681(19)31979-9" "estado" => "S300" "fechaPublicacion" => "2006-01-01" "aid" => "71638" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Ann Hepatol. 2006;5 Supl 1:S69-73" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 43 "formatos" => array:3 [ "EPUB" => 6 "HTML" => 12 "PDF" => 25 ] ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "Cost efficacy and cost-benefit of treatment of hepatitis C" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "S69" "paginaFinal" => "S73" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Juan Francisco Sánchez Ávila" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Juan Francisco" "apellidos" => "Sánchez Ávila" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119319799?idApp=UINPBA00004N" "url" => "/16652681/00000005000000S1/v1_201906280857/S1665268119319799/v1_201906280857/en/main.assets" ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Medical-legal implications of hepatitis C virus infection" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "S74" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Misael Uribe" "autores" => array:1 [ 0 => array:4 [ "nombre" => "Misael" "apellidos" => "Uribe" "email" => array:1 [ 0 => "muribe@medicasur.org.mx" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "aff1" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor1" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:3 [ "entidad" => "Departamento de Gastroenterología, Instituto Nacional de Nutrición y Ciencias Médicas “Salvador Zubirán”, México, D.F., México" "etiqueta" => "1" "identificador" => "aff1" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor1" "etiqueta" => "*" "correspondencia" => "Address for correspondence:" ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="p0005" class="elsevierStylePara elsevierViewall">Does chronic hepatitis C virus (HCV) infection prevent patients from working?</p><p id="p0010" class="elsevierStylePara elsevierViewall">The effect of HCV infection on work activities depends on the patient’s personality. When notified that they have a chronic infection, some people develop anxiety, depression, insomnia, headache, and irritability, which are unrelated to etiology of the disease <span class="elsevierStyleItalic">per se</span>. There are few ways in which a physician can objectively conclude that the patient suffers from a disability secondary to the infection, especially in previously asymptomatic patients with normal aminotransferase levels.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Objective symptomatology</span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">1. Symptoms related to the disease</span><p id="p0015" class="elsevierStylePara elsevierViewall">Some patients do not display symptoms for several years after contracting hepatitis C even though their aminotransferase levels are elevated. On the other hand, patients with cirrhosis may exhibit portal hypertension, liver encephalopathy, digestive tube bleeding, or spontaneous peritonitis. These complications require a period of rest subsequent to hospitalization. Patient protection committees in the United States, Europe, and Canada have established minimum and maximum terms of domiciliary rest for each type of complication related to hepatitis C.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">2. Causes of treatment-related disability</span><p id="p0020" class="elsevierStylePara elsevierViewall">Many treatments for hepatitis C cause disabilities. Interferon produces symptoms similar to those of acute flu: fatigue, myalgia, fever, and a general feeling of sickness. Ribavirin induces neutropenia, anemia and thrombocytopenia. Liver transplant patients are unable to work for a lengthy period after the operation. The duration and grading of the disability should be modified if the graft requires treatment with drugs such as cyclosporine or is rejected.</p><p id="p0025" class="elsevierStylePara elsevierViewall">Is a pension or relocation justifiable for medical or paramedical personnel who contract hepatitis C?</p><p id="p0030" class="elsevierStylePara elsevierViewall">In Canada, Europe, and the United States the total cost of treatment, including the cost of psychiatry in the event of depression or the cost of liver transplantation, if applicable, is reimbursed to medical and paramedical personnel. An additional sum is paid to cover loss of income in the event of disability, and the patient receives a monthly pension for a period determined by his/her doctor and an institutional committee.</p><p id="p0035" class="elsevierStylePara elsevierViewall">New cases of hepatitis C infection occur every two to three years among medical and paramedical personnel at Calgary Hospital, Canada. The infections are mainly acquired by needle punctures. Most legal cases are resolved in favor of the patients, as there are law firms who have experts in litigation on behalf of hepatitis C patients. Such firms attempt to procure a judgment of relocation or even retirement in the event of liver failure or its complications.</p><p id="p0040" class="elsevierStylePara elsevierViewall">Question number 3. The answer is: if the patient as above mentioned has previously gone through several mental and physical disability periods, because of the disease and treatment and in any case, his/her doctor and a group of experts may determine so.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Recommendations of the consensus panel</span><p id="p0045" class="elsevierStylePara elsevierViewall">Is chronic infection usually an impediment for work-related activities?</p><p id="p0050" class="elsevierStylePara elsevierViewall">Chronic infection with the hepatitis C virus <span class="elsevierStyleItalic">per se</span> does not impede work performance.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Evidence quality: 3</span><p id="p0055" class="elsevierStylePara elsevierViewall">Are pensions or relocations justified for HCV-positive personnel such as surgeons, specialized nurses, gynecologists, and deontologists who do not attain sustained virological responses?</p><p id="p0060" class="elsevierStylePara elsevierViewall">Consensus was not reached.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Evidence quality: 3</span><p id="p0065" class="elsevierStylePara elsevierViewall">Is temporary disability necessary during treatment for HCV?</p><p id="p0070" class="elsevierStylePara elsevierViewall">The need for temporary disability during antiviral treatment should be evaluated on an individual basis.</p><p id="sect0035" class="elsevierStylePara elsevierViewall">Evidence quality: 3</p></span></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:1 [ 0 => array:3 [ "identificador" => "sec0005" "titulo" => "Objective symptomatology" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0010" "titulo" => "1. Symptoms related to the disease" ] 1 => array:2 [ "identificador" => "sec0015" "titulo" => "2. Causes of treatment-related disability" ] 2 => array:2 [ "identificador" => "sec0020" "titulo" => "Recommendations of the consensus panel" ] 3 => array:2 [ "identificador" => "sec0025" "titulo" => "Evidence quality: 3" ] 4 => array:2 [ "identificador" => "sec0030" "titulo" => "Evidence quality: 3" ] ] ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true ] "idiomaDefecto" => "en" "url" => "/16652681/00000005000000S1/v1_201906280857/S1665268119319805/v1_201906280857/en/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/16652681/00000005000000S1/v1_201906280857/S1665268119319805/v1_201906280857/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119319805?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 1 | 0 | 1 |
2024 October | 4 | 0 | 4 |
2024 September | 18 | 1 | 19 |
2024 August | 7 | 4 | 11 |
2024 July | 7 | 5 | 12 |
2024 June | 7 | 0 | 7 |
2024 May | 5 | 2 | 7 |
2024 April | 9 | 0 | 9 |
2024 March | 6 | 4 | 10 |
2024 February | 7 | 1 | 8 |
2024 January | 4 | 3 | 7 |
2023 December | 5 | 5 | 10 |
2023 November | 2 | 5 | 7 |
2023 October | 4 | 2 | 6 |
2023 September | 7 | 3 | 10 |
2023 August | 2 | 1 | 3 |
2023 July | 1 | 1 | 2 |
2023 June | 3 | 4 | 7 |
2023 May | 2 | 4 | 6 |
2023 April | 4 | 1 | 5 |
2023 February | 3 | 2 | 5 |
2023 January | 2 | 3 | 5 |
2022 December | 6 | 2 | 8 |
2022 November | 7 | 4 | 11 |
2022 October | 6 | 3 | 9 |
2022 September | 7 | 20 | 27 |
2022 August | 5 | 3 | 8 |
2022 July | 7 | 8 | 15 |
2022 June | 4 | 6 | 10 |
2022 May | 7 | 5 | 12 |
2022 April | 8 | 7 | 15 |
2022 March | 7 | 5 | 12 |
2022 February | 4 | 4 | 8 |
2022 January | 5 | 4 | 9 |
2021 December | 5 | 6 | 11 |
2021 November | 4 | 6 | 10 |
2021 October | 5 | 12 | 17 |
2021 September | 4 | 5 | 9 |
2021 August | 3 | 3 | 6 |
2021 July | 8 | 6 | 14 |
2021 June | 4 | 3 | 7 |
2021 May | 9 | 6 | 15 |
2021 April | 9 | 17 | 26 |
2021 March | 3 | 6 | 9 |
2021 February | 1 | 3 | 4 |
2021 January | 4 | 8 | 12 |
2020 December | 4 | 2 | 6 |
2020 November | 3 | 4 | 7 |
2020 October | 3 | 2 | 5 |
2020 September | 4 | 4 | 8 |
2020 August | 1 | 1 | 2 |
2020 July | 3 | 1 | 4 |
2020 June | 2 | 2 | 4 |
2020 May | 2 | 3 | 5 |
2020 April | 2 | 7 | 9 |
2020 March | 3 | 1 | 4 |
2020 February | 1 | 1 | 2 |
2020 January | 3 | 5 | 8 |
2019 December | 4 | 3 | 7 |
2019 October | 1 | 1 | 2 |
2019 August | 1 | 1 | 2 |
2019 July | 2 | 10 | 12 |
2019 June | 2 | 6 | 8 |